New developments in the antiviral treatment of hepatitis C

被引：10
|
作者：
de Bruijne, J. [1 ]
Weegink, C. J. [1 ]
Jansen, P. L. M. [1 ]
Reesink, H. W. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
VOX SANGUINIS | 2009年 / 97卷 / 01期
关键词：
PROTEASE INHIBITOR; PEGINTERFERON ALPHA-2A; INITIAL TREATMENT; VIRAL-HEPATITIS; PLUS RIBAVIRIN; DOUBLE-BLIND; VIRUS; COMBINATION; INTERFERON-ALPHA-2B; EPIDEMIOLOGY;
D O I：
10.1111/j.1423-0410.2009.01187.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recently, reliable in vitro culture systems have been developed which accelerated antiviral therapy research. Many new specifically targeted antiviral therapies for hepatitis C (STAT-C) and treatment strategies are evaluated in clinical trials. These new antiviral agents are expected to improve treatment significantly with potentially shorter treatment duration. The most promising antiviral agents will be reviewed.
引用
收藏
页码：1 / 12
页数：12
相关论文
共 50 条
  • [41] Recent Developments in the Treatment of Chronic Hepatitis C
    Page, Jeni
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2012, 8 (03): : 225 - 230
  • [42] Antiviral treatment for cirrhosis due to hepatitis C: a review
    Somasundaram, Aravindh
    Venkataraman, Jayanthi
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (04) : 231 - 235
  • [43] Ophthalmologic complications of antiviral therapy in hepatitis C treatment
    Roderick O'Day
    Mark C Gillies
    Golo Ahlenstiel
    World Journal of Gastroenterology, 2013, (45) : 8227 - 8237
  • [44] Antiviral treatment initiation costs in chronic hepatitis C
    Siebert, U
    Wasem, J
    Rossol, S
    Sroczynski, G
    Aidelsburger, P
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2005, 54 (01) : 172 - 173
  • [45] Antiviral treatment for hepatitis C cirrhosis: Is the effort justified?
    Black, Martin
    Thomas, Rebecca
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (06) : 427 - W80
  • [46] Combined antiviral options for the treatment of chronic hepatitis C
    Medina, J
    García-Buey, L
    Moreno-Monteagudo, JA
    Trapero-Marugán, M
    Moreno-Otero, R
    ANTIVIRAL RESEARCH, 2003, 60 (02) : 135 - 143
  • [47] New antiviral treatment of HCV infected young haemophiliacs -expectations to cure hepatitis C
    Koehler-Vajta, K.
    Denk, G.
    Wettstein, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 347 - 347
  • [48] An update on direct antiviral agents for the treatment of hepatitis C
    Stanciu, Carol
    Muzica, Cristina Maria
    Girleanu, Irina
    Cojocariu, Camelia
    Sfarti, Catalin
    Singeap, Ana-Maria
    Huiban, Laura
    Chiriac, Stefan
    Cuciureanu, Tudor
    Trifan, Anca
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (13) : 1729 - 1741
  • [49] Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
    Spengler, Ulrich
    PHARMACOLOGY & THERAPEUTICS, 2018, 183 : 118 - 126
  • [50] Schistosomiasis and antiviral treatment of chronic hepatitis C -: Reply
    Paraná, R
    Codes, L
    Andrade, Z
    HEPATOLOGY, 2001, 34 (04) : 850 - 851
12345